[1]孙朝霞,曹显刚,赵 利,等.发热伴血小板减少综合征患者D-二聚体、心肌酶谱及肝酶谱的检测[J].医学信息,2018,31(03):85-87,91.[doi:10.3969/j.issn.1006-1959.2018.03.026]
　SUN Zhao-xia,CAO Xian-gang,ZHAO li,et al.Detection of D-Dimer,Myocardial and Liver Enzymes in Patients with Fever and Thrombocytopenia Syndrome[J].Journal of Medical Information,2018,31(03):85-87,91.[doi:10.3969/j.issn.1006-1959.2018.03.026]
点击复制

发热伴血小板减少综合征患者D-二聚体、心肌酶谱及肝酶谱的检测()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年03期
页码:
85-87,91
栏目:
论著
出版日期:
2018-02-01

文章信息/Info

Title:
Detection of D-Dimer,Myocardial and Liver Enzymes in Patients with Fever and Thrombocytopenia Syndrome
文章编号:
1006-1959（2018）03-0085-04
作者:
孙朝霞; 曹显刚; 赵 利; 倪秀莹; 吴翠萍
山东省潍坊市益都中心医院感染科，山东 青州 262500
Author(s):
SUN Zhao-xia; CAO Xian-gang; ZHAO li; NI Xiu-ying; WU Cui-ping
Department of Nosocomial Infection,Yidu Center hospital,Qingzhou 262500,Shandong,China
关键词:
发热伴血小板减少综合征; D-二聚体; 心肌酶谱; 肝酶谱
Keywords:
Fever accompanied by thrombocytopenia syndrome; D-Dimer; Myocardial enzyme spectrum; Liver enzyme spectrum
分类号:
R446.1
DOI:
10.3969/j.issn.1006-1959.2018.03.026
文献标志码:
A
摘要:
目的 探讨本地区发热伴血小板减少综合征患者发热期、多器官功能障碍期、恢复期三期D-二聚体、心肌酶谱和肝酶谱的动态变化规律，研究其临床意义。方法 我院2011年3月~ 2015年12月收住院的124例发热伴血小板减少综合征患者回顾性分析。患者入院及后每2 d进行D-二聚体检测，早晨采空腹静脉血送检心肌酶谱、肝酶谱检测，至恢复期患者出院，记录各数据，进行统计学分析。结果 发热期D-二聚体水平（2231.4±158.6）μg/L、多器官障碍期D-二聚体水平（1520.5±106.7）μg/L，与恢复期D-二聚体水平（321.9±35.3）μg/L相比，发热期、多器官障碍期D-二聚体水平明显升高，差异有统计学差异（P<0.01）；多器官功能障碍期AST（183.1±67.1）U/L与发热期AST（372.9±90.0）U/L、恢复期AST（95.8±34.3）U/L对比明显升高，差异有统计学意义（P<0.05）；普通型AST水平（259.8±65.8）U/L低于危重型AST水平（428.6±140），差异有统计学差异（P<0.05）；普通型LDH（305.4±132.0）U/L、CK（284.4±118.0）U/L、CK-MB（96.5±18.8）U/L与危重型LDH（3902.3±187.4）U/L、CK（799.8±437.3）U/L、CK-MB（206.1±51.4）U/L对比差异有统计学意义（P<0.01），普通型ALT（96.66±42.16）、AST（156.1±37.1）与危重型ALT（372.9±61.6）、AST（651.8±34.3）比较差异显著，存在统计学差异（P<0.01）。结论 发热伴血小板减少综合征患者D-二聚体、心肌酶谱早期便出现异常改变，且病情越重，D-二聚体、心肌酶谱升高越明显，但肝酶谱的改变有一定的滞后性，早期检测D-二聚体、CK水平可以识别发热伴血小板减少综合征危重病例、D-二聚体、CK水平下降预示病情好转，可以指导预后。
Abstract:
Objective To investigate the dynamic changes of D-dimer,myocardial enzyme spectrum and hepatic enzyme spectrum in patients who have fever accompanied by thrombocytopenia syndrome during the febrile,multiple organ dysfunction and convalescence period,study on its clinical significance as well.Methods From March 2011 to December 2015,124 cases of fever accompanied by thrombocytopenia syndrome were retrospectively analyzed.D-dimer was detected every 2 days after admission.In the morning,fasting venous blood was collected to test myocardial enzyme spectrum and liver enzyme spectrum,and the patients were discharged from the convalescence period.The data were recorded and analyzed statistically.Results The D-dimer level was（2231.4±158.6）μg/L during the febrile period and（1520.5±106.7）μg/L during multiple organ dysfunction period.Compared with convalescent D-dimer level （321.9±35.3）μg/L,D- dimer level in febrile period and multiple organ dysfunction period was significantly higher than that in convalescent period(P<0.01).AST level（183.1±67.1）U/L during multiple organ dysfunction period is significantly higher compared with that during the febrile period（372.9±90.0）U/L and convalescence period（95.8±34.3）U/L,the difference was statistically significant (P<0.05).LDH of common type（305.4±132.0）U/L、CK（284.4±118.0）U/L、CK-MB（96.5±18.8）U/L compared with LDH of critical type（3902.3±187.4）U/L、CK（799.8±437.3）U/L、CK-MB（206.1±51.4）U/L, there was statistical difference(P<0.01).And,ALT（96.66±42.16）、AST（156.1±37.1）of common type compared with critical type ALT（372.9±61.6）、AST（651.8±34.3）,there was statistical difference(P<0.01).Conclusion In patients with fever accompanied by thrombocytopenia syndrome,abnormal changes of D-dimer and myocardial zymogram occur at the early stage,and the more serious the disease is,the more obvious the increase of D-dimer and myocardial enzyme spectrum are in patients with fever accompanied by thrombocytopenia syndrome.But the change of liver enzyme spectrum has a certain lag,early detection of D-dimer and CK level can identify the fever accompanied by thrombocytopenia syndrome in critical cases,the decrease of D-dimer and CK level indicates the improvement of the condition.It can guide the prognosis.

参考文献/References:

[1]关文竹,新布尼亚病毒的流行病学及临床特征 [J].微生物学免疫学进展,2016,44(4):75-76.
[2]孙朝霞,曹显刚,赵利.发热伴血小板减少综合征患者早期D-二聚体水平的检测及临床意义[C]//中华预防医学与临床医学论文汇编.2015.
[3]Yoo S J,Sang T H,Lee K H.Severe Fever with Thrombocytopenia Syndrome[J].Korean Journal of Critical Care Medicine,2014,29(2):59.
[4]Li J,Han Y,Xing Y,et al.Concurrent measurement of dynamic changes in viral load,serum enzymes,T cell subsets,and cytokines in patients with severe fever with thrombocytopenia syndrome.[J].Plos One,2014,9(3):167-169.
[5]吴翠萍,赵利,曹显刚.发热伴血小板减少综合征心肌酶谱动态变化的临床研究[J].临床输血与检验, 2015,17(5):389-391.
[6]徐哲,崔宁,陈威巍,等.422例发热伴血小板减少综合征临床特点分析[J].传染病信,2015(1):28-32.
[7]王丽,刘靓雯,冯兆雷,等.实时RT-PCR与ELISA在发热伴血小板减少综合征检测中的应用[J].中华实验和临床病毒学杂志,2015,29(4):351-353.
[8]Jie SH,Zhou Y,Sun LP,et al.Close correlation between development of MODS during the initial 72h of hospitaiazation and hospital mortality in severefever with thrombocytopenia syndrome [J].J Huazhong U niv Sci Technol,2013,33(1):81-85.
[9]韩亚萍,陈念,金柯,等.严重发热伴血小板减少综合征疾病程度的相关实验室指标筛选[J].中华检验医学杂志,2015,38(1):49-54.
[10]叶小红,张慧利,郑建军.2012-2014临海市发热伴血小板减少综合征流行特点及病原学监测结果分析[J].中国病原生物学杂志,2015(3):265-267.
[11]Shin J,Kwon D,Youn S K,et al.Characteristics and Factors Associated with Death among Patients Hospitalized for Severe Fever with Thrombocytopenia Syndrome,South Korea,2013[J].Emerging Infectious Diseases,2015,21(10):1704.
[12]Yu F,Du Y,Huang X,et al.Application of recombinant severe fever with thrombocytopenia syndrome virus nucleocapsid protein for the detection of SFTSV-specific human IgG and IgM antibodies by indirect ELISA[J].Virology Journal,2015,12(1):117.
[13]魏艳艳,邹桂舟,叶珺,等.新型布尼亚病毒感染致发热伴血小板减少综合征临床特点及血常规和血清酶学分析[J].安徽医药,2016,20(5):903-907.
[14]程宁宁,杜燕华,黄学勇,等.发热伴血小板减少综合征实验室诊断方法的比较与评价[J].天津医药, 2017,45(2):210-214.
[15]易波,高丽,孔志芳,等.宁波发热伴血小板减少综合征流行病学监测结果分析[J].浙江预防医学, 2015(2):127-130.

相似文献/References:

[1]和珍珍,吴彦洪,刘艳,等.凝血指标测定对诊断胎盘早剥的价值分析[J].医学信息,2018,31(01):153.[doi:10.3969/j.issn.1006-1959.2018.01.060]
　HE Zhen-zhen,WU Yan-hong,LIU Yan,et al.Value Analysis of Coagulation Index in Diagnosing Placental Abruption[J].Journal of Medical Information,2018,31(03):153.[doi:10.3969/j.issn.1006-1959.2018.01.060]
[2]赵华莹,李运泽,韦天灵,等.肝硬化合并门静脉血栓形成的危险因素分析[J].医学信息,2019,32(03):86.[doi:10.3969/j.issn.1006-1959.2019.03.026]
　ZHAO Hua-ying,LI Yun-ze,WEI Tian-ling,et al.Analysis of Risk Factors for Cirrhotic Patients with Portal Vein Thrombosis[J].Journal of Medical Information,2019,32(03):86.[doi:10.3969/j.issn.1006-1959.2019.03.026]
[3]付云杰.肺癌患者血浆D-二聚体、NSE及CYFRA21-1联合检测的临床价值[J].医学信息,2018,31(23):161.[doi:10.3969/j.issn.1006-1959.2018.23.047]
　FU Yun-jie.Clinical Value of the Plasma D-dimer and Serum NSE,CYFRA21-1 Combined Detection in the Diagnosis of Lung Cancer[J].Journal of Medical Information,2018,31(03):161.[doi:10.3969/j.issn.1006-1959.2018.23.047]
[4]宫园园.LDL、Hcy、D-二聚体及颈动脉粥样硬化与急性缺血性脑卒中相关性研究[J].医学信息,2019,32(05):117.[doi:10.3969/j.issn.1006-1959.2019.05.036]
　GONG Yuan-yuan.Correlation between LDL,Hcy,D-dimer and Carotid Atherosclerosis and Acute Ischemic Stroke[J].Journal of Medical Information,2019,32(03):117.[doi:10.3969/j.issn.1006-1959.2019.05.036]
[5]祁 闻,赵 红,王龙胜,等.肺栓塞CTPA间接征象诊断价值分析及临床意义[J].医学信息,2019,32(08):88.[doi:10.3969/j.issn.1006-1959.2019.08.026]
　QI Wen,ZHAO Hong,WANG Long-sheng,et al.Diagnostic Value and Clinical Significance of CTPA indirect signs in Pulmonary Embolism[J].Journal of Medical Information,2019,32(03):88.[doi:10.3969/j.issn.1006-1959.2019.08.026]
[6]杜治国,何 龙,黄 进,等.下肢创伤骨折后静脉血栓栓塞症相关检测项目分析[J].医学信息,2019,32(10):64.[doi:10.3969/j.issn.1006-1959.2019.10.022]
　DU Zhi-guo,HE Long,HUANG Jin,et al.Analysis of Related Items of Venous Thromboembolism after Traumatic Fracture of Lower Extremity[J].Journal of Medical Information,2019,32(03):64.[doi:10.3969/j.issn.1006-1959.2019.10.022]
[7]张利敏,游 婕,朱陈华,等.脂联素和D-二聚体在急性主动脉夹层中的诊断价值[J].医学信息,2022,35(14):62.[doi:10.3969/j.issn.1006-1959.2022.14.013]
　ZHANG Li-min,YOU Jie,ZHU Chen-hua,et al.Diagnostic Value of Adiponectin and D-dimer in Acute Aortic Dissection[J].Journal of Medical Information,2022,35(03):62.[doi:10.3969/j.issn.1006-1959.2022.14.013]
[8]李大千,蒋 云,梅燕萍.抗凝血酶Ⅲ、D-二聚体与纤维蛋白原在 下肢静脉血栓形成中的临床应用[J].医学信息,2019,32(17):167.[doi:10.3969/j.issn.1006-1959.2019.17.057]
　LI Da-qian,JIANG Yun,MEI Yan-ping.Clinical Application of Antithrombin III,D-dimer and Fibrinogen in Venous Thrombosis of Lower Extremity[J].Journal of Medical Information,2019,32(03):167.[doi:10.3969/j.issn.1006-1959.2019.17.057]
[9]龚嘉玮,朱旭日,徐 锋,等.化瘀定痛液联合低分子肝素治疗老年粗隆间骨折围手术期肿痛的效果[J].医学信息,2020,33(03):148.[doi:10.3969/j.issn.1006-1959.2020.03.048]
　GONG Jia-wei,ZHU Xu-ri,XU Feng,et al.Effect of Huayudingtong Liquid Combined with Low-molecular-weight Heparin on Perioperative Swelling and Pain in Elderly Intertrochanteric Fractures[J].Journal of Medical Information,2020,33(03):148.[doi:10.3969/j.issn.1006-1959.2020.03.048]
[10]阙禄辉.闭合性骨折后下肢DVT患者D-二聚体、纤维蛋白原与Caprini评分的相关性分析[J].医学信息,2020,33(04):101.[doi:10.3969/j.issn.1006-1959.2020.04.030]
　QUE Lu-hui.Correlation Analysis of D-Dimer,Fibrinogen and Caprini Score in Patients with Lower Extremity DVT After Closed Fracture[J].Journal of Medical Information,2020,33(03):101.[doi:10.3969/j.issn.1006-1959.2020.04.030]

更新日期/Last Update: 2018-02-01